Back to top
more

Baxter International (BAX)

(Delayed Data from NYSE)

$36.91 USD

36.91
4,316,313

-1.06 (-2.79%)

Updated Oct 1, 2024 04:00 PM ET

Pre-Market: $36.91 0.00 (0.00%) 9:20 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (50 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

FDA OKs Medtronic's Evolut TAVR New Indication for Low Risk

With the FDA's expanded indication nod, Medtronic's (MDT) Evolut TAVR platform now comes in handy for treating symptomatic severe aortic stenosis patients across all risk categories.

Here's Why You Should Hold on to McKesson (MCK) Stock Now

McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market.

Here's Why You Should Add Stryker (SYK) to Your Portfolio

Stryker (SYK) gains from core segments in the second quarter of 2019.

Restoration Robotics (HAIR) Wins CE Mark for ARTAS iX System

This regulatory approval is expected to strengthen Restoration Robotics' (HAIR) hair restoration business and expand its presence globally.

Medtronic (MDT) Beats on Q1 Earnings, Ups FY20 EPS Guidance

Medtronic (MDT) displays improved performances at CER, banking on growth across all major segmental businesses as well as geographies.

BAX vs. BSX: Which Stock Is the Better Value Option?

BAX vs. BSX: Which Stock Is the Better Value Option?

Here's Why You Should Hold Varian Medical (VAR) Stock Now

Varian (VAR) raises the revenue guidance for fiscal 2019.

Walgreens (WBA) Expands Partnership With Retail Giant Kroger

The extended partnership deal with Kroger will help Walgreens (WBA) strengthen its market presence.

Here's Why You Should Hold Onto IDEXX (IDXX) Stock for Now

Investor confidence continues to be high on IDEXX Laboratories' (IDXX) prospects.

Here's Why You Should Invest in DaVita (DVA) Stock For Now

DaVita (DVA) continues to benefit from international expansion, strategic buyouts and strong demand of dialysis services.

Here's Why You Should Retain Nevro (NVRO) in Your Portfolio

Nevro (NVRO) is gaining traction from a fortified international footprint and solid prospects in the SCS market. However, stiff competition remains a woe.

Here's Why You Should Retain Wright Medical Stock For Now

Wright Medical (WMGI) continues to benefit from strong international sales, new product launches and solid prospects in the global Orthopedic space. However, forex remains a woe.

Edwards Lifesciences' (EW) SAPIEN 3 TAVR Receives FDA Nod

Edwards Lifesciences (EW) plans a commercial introduction of SAPIEN 3 Ultra in Europe.

Here's Why You Should Hold Onto Omnicell (OMCL) Stock for Now

Investor confidence continues to be high on Omnicell's (OMCL) prospects.

QIAGEN Posts QIAstat-Dx Gastrointestinal Panel Study Results

The study outcome has been a major step for QIAGEN (QGEN) toward offering accurate diagnosis and treatment of gastroenteritis.

Here's Why You Should Snap Up Baxter International (BAX) Now

For 2019, Baxter (BAX) expects adjusted earnings per share within $3.34-$3.40.

Accuray (ARAY) Reports Loss in Q4, Revenues Beat Estimates

Accuray (ARAY) expects fiscal 2020 revenues to be impacted by China tariffs.

The Zacks Analyst Blog Highlights: Deere, Baxter, EPAM Systems, NiSource and Universal Display

The Zacks Analyst Blog Highlights: Deere, Baxter, EPAM Systems, NiSource and Universal Display

Baxter's PrisMax Adopted by Hamilton Health Care System

Baxter's (BAX) PrisMax System first adopted by Hamilton Health, which in turn is expected to enhance patient care.

Mark Vickery headshot

Top Analyst Reports: Deere, Baxter & More

Today's Research Daily features updated research reports on 11 major stocks, including Deere (DE) and Baxter (BAX).

CVS Health Banks on Health Care Benefit Prospects Amid Woes

CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition is gaining a strong momentum.

ResMed (RMD) Hits a New 52-Week High: What's Driving It?

ResMed (RMD) gains from promising financial results in the fourth quarter of fiscal 2019.

Here's Why You Should Hold Onto Insulet (PODD) Stock for Now

Investor confidence continues to be high on Insulet's (PODD) solid prospects.

Myriad Genetics (MYGN) Q4 Earnings Lag Estimates, Revenues Up

Myriad Genetics' (MYGN) overall Q4 performance is impressive, excepting weak sales at a few segments.

Zacks.com featured highlights include: Abbott Laboratories, Baxter International, First Horizon National, OUTFRONT Media and ICF International

Zacks.com featured highlights include: Abbott Laboratories, Baxter International, First Horizon National, OUTFRONT Media and ICF International